SCHEMBL593379

SCHEMBL593379

CCCCCCCC/C=C/C=C/OC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FASN P49327 1/20 0.58
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.50
FAAH O00519 4/20 0.49
KDM4E B2RXH2 1/20 0.49
TERT O14746 3/20 0.47
MAPT P10636 2/20 0.47
BLM P54132 2/20 0.47
HSD17B10 Q99714 2/20 0.47
FABP4 P15090 2/20 0.47
PTPN1 P18031 2/20 0.47
PPARG P37231 2/20 0.47
PPARD Q03181 2/20 0.47
PPARA Q07869 2/20 0.47
GMNN O75496 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11333792 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL593500 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL10349439 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL593501 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL3251757 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL593380 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL8633543 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL20503685 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL20503686 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E
SCHEMBL6295737 1.00 FASN (0.58) FASNALDH1A1TSHRFAAHKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4077636-A1 YEAST CELLS AND METHODS FOR PRODUCTION OF E8,E10-DODECADIENYL COENZYME A, CODLEMONE AND DERIVATIVES THEREOF BioPhero ApS (DK) 2022-10-26 EP claimed
EP-4059348-A1 MIXTURE OF A FOLCYSTEINE-BASED BIOSTIMULANT AND AN AGROTOXIC SUBSTANCE OF INTEREST RESULTING IN A QUANTITATIVELY, QUALITATIVELY AND TIME-RELATED RESULT-POTENTIATING ACTION AS OBSERVED IN AN AGRICULTURAL CROP OF A PLANT OF INTEREST UPL Corporation Limited (MU) 2022-09-21 EP claimed
EP-4048804-A1 IMPROVED METHODS FOR PRODUCTION, RECOVERY AND SECRETION OF HYDROPHOBIC COMPOUNDS IN A FERMENTATION BioPhero ApS (DK) 2022-08-31 EP claimed
US-11076600-B2 Mixtures of cis-jasmone and bacillus amyloliquefaciens BASF SE (DE) 2021-08-03 US claimed
EP-3679796-A1 MIXTURE OF A FOLCYSTEINE-BASED BIOSTIMULANT AND AN AGROTOXIC SUBSTANCE OF INTEREST RESULTING IN A QUANTITATIVELY, QUALITATIVELY AND TIME-RELATED RESULT-POTENTIATING ACTION AS OBSERVED IN AN AGRICULTURAL CROP OF A PLANT OF INTEREST UPL Corporation Limited (MU) 2020-07-15 EP claimed
US-20180317498-A1 Mixtures of Cis-Jasmone and Bacillus Amyloliquefaciens BASF SE (DE) 2018-11-08 US claimed
EP-3376859-A1 MICROORGANISMS FOR THE PRODUCTION OF INSECT PHEROMONES AND RELATED COMPOUNDS Provivi, Inc. (US) 2018-09-26 EP claimed
EP-2365950-B1 PRODUCTION OF PHEROMONES AND FRAGRANCES FROM SUBSTITUTED AND UNSUBSTITUTED 1-ALKEN-3-YL ALKYLATES BEDOUKIAN RES INC (US) 2014-10-29 EP claimed
EP-2365950-A1 PRODUCTION OF PHEROMONES AND FRAGRANCES FROM SUBSTITUTED AND UNSUBSTITUTED 1-ALKEN-3-YL ALKYLATES Bedoukian Research, Inc. (US) 2011-09-21 EP claimed
US-7932410-B2 Production of pheromones and fragrances from substituted and unsubstituted 1-alken-3yl alkylates BEDOUKIAN RESEARCH, INC. (US) 2011-04-26 US claimed
EP-2191717-A2 Acetate-containing mating disruptant and mating distruption method using the same Shin-Etsu Chemical Co., Ltd. (JP) 2010-06-02 EP claimed
US-20100113837-A1 Production of pheromones and fragrances from substituted and unsubstituted 1-alken-3yl alkylates BEDOUKIAN RESEARCH, INC. 2010-05-06 US claimed
WO-2010051028-A1 PRODUCTION OF PHEROMONES AND FRAGRANCES FROM SUBSTITUTED AND UNSUBSTITUTED 1-ALKEN-3-YL ALKYLATES BEDOUKIAN RESEARCH, INC. (US) 2010-05-06 WO claimed
US-20100021417-A1 ACETATE-CONTAINING MATING DISRUPTANT AND MATING DISRUPTION METHOD USING THE SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-01-28 US claimed
EP-1221836-A4 NOVEL BISEXUAL ATTRACTANTS, AGGREGANTS AND ARRESTANTS FOR ADULTS AND LARVAE OF CODLING MOTH AND OTHER SPECIES OF i LEPIDOPTERA /i TRECE INC (US) 2004-04-21 EP claimed
EP-1051069-B1 DEVICE FOR LURING AND CATCHING INSECTS LOHMANN THERAPIE SYST LTS (DE) 2003-04-02 EP claimed
US-6505434-B1 Device for luring and catching insects LTS LOHMANN THERAPIE-SYSTEME AG (DE) 2003-01-14 US claimed
EP-1221836-A1 NOVEL BISEXUAL ATTRACTANTS, AGGREGANTS AND ARRESTANTS FOR ADULTS AND LARVAE OF CODLING MOTH AND OTHER SPECIES OF i LEPIDOPTERA /i Trece Incorporated (US) 2002-07-17 EP claimed
WO-2001039766-A2 SCREENING INVERTEBRATE PHEROMONES FOR THERAPEUTIC ACTIVITY ALYDAR PHARMACEUTICALS LTD. (IL) 2001-06-07 WO claimed
WO-2001028327-A1 NOVEL BISEXUAL ATTRACTANTS, AGGREGANTS AND ARRESTANTS FOR ADULTS AND LARVAE OF CODLING MOTH AND OTHER SPECIES OF LEPIDOPTERA TRECE INCORPORATED (US) 2001-04-26 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11076600-B2 Mixtures of cis-jasmone and bacillus amyloliquefaciens BAX, FASN, BAK1 FASN 2/4885ALDH1A1 4217/4885TSHR 3364/4885
US-20180317498-A1 Mixtures of Cis-Jasmone and Bacillus Amyloliquefaciens BAX, FASN, BAK1 FASN 2/4885ALDH1A1 4217/4885TSHR 3364/4885
US-20100113837-A1 Production of pheromones and fragrances from substituted and unsubstituted 1-alken-3yl alkylates OR51E2, AR, NAA50 FASN 39/4885ALDH1A1 832/4885TSHR 2656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.